Despite being the most effective strategy for reducing OHSS, a GnRH agonist trigger does not eliminate severe cases in all high-risk patients. This study provides important data on the characteristics of women who remain susceptible, helping refine prevention strategies and guide safer, evidence-based stimulation approaches.
